FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmacology and urology, namely to a composition aimed at eliminating symptoms of chronic prostatitis and/or chronic pelvic pain syndrome. Disclosed composition has antioxidant, anti-inflammatory activity and contains: lycopene – 10 mg, selenomethionine – 0.07 mg (in terms of selenium), quercetin – 100 mg, zinc citrate or zinc picolinate – 12 mg (in terms of zinc), naringin – 200 mg.
EFFECT: invention provides higher efficacy of the composition, improved bioavailability of its active substances, reduced risks of hepatoxicity and bleeding.
1 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PROSTATE PATHOLOGIES | 2017 |
|
RU2750992C2 |
| COMBINATIONS OF EXTRACTS SERENOA REPENS AND LIPOPHILIC EXTRACTS ZINGIBER OFFICINALIS AND ECHINACEA ANGUSTIFOLIA, USE THEREOF AND COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2659153C2 |
| METHOD FOR TREATMENT OF CHRONIC ABACTERIAL PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME, COMBINED WITH ERECTILE DYSFUNCTION | 2016 |
|
RU2647478C2 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| METHOD OF TREATING CHRONIC PROSTATITIS | 2008 |
|
RU2408378C2 |
| METHOD FOR TREATING CHRONIC ABACTERIAL PROSTATITIS/SYNDROME OF CHRONIC NONINFLAMMATORY PELVIC PAIN | 2003 |
|
RU2285445C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF INFLAMMATORY AND UNINFLAMMATORY FORMS OF CHRONIC ABACTERIAL PROSTATITIS | 2010 |
|
RU2428932C1 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| METHOD OF TREATING AND PREVENTING LOWER URINARY TRACT SYMPTOMS IN MALES USING NORTHERN WALKING TECHNIQUE | 2019 |
|
RU2726993C1 |
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
